Impact of Introducing Infliximab Biosimilars on Total Infliximab Consumption and Originator Infliximab Prices in Eight Regions: An Interrupted Time-Series Analysis.

A stable trend was observed in Hong Kong ( P = 0.605) and the UK ( P = 0.155), while in the USA there was an increasing trend in price where the originator infliximab price increased at a rate of 5.14 USD/SU per quarter [( P < 0.001), Fig. 3 ; Table 2 ].

also in 14,538 other papers

Before biosimilars were introduced, originator infliximab prices presented a decreasing trend in Australia ( P = 0.002), Canada ( P < 0.001), India ( P < 0.001), Japan ( P < 0.001), and Korea ( P < 0.001).

also in 11,207 other papers